German Parliament Debates Prenatal Tests - Motion Calls for Broader Data Basis - Germany debates stricter rules for prenatal genetic testing amid ethical concerns

German lawmakers have debated stricter controls on non-invasive prenatal tests (NIPT). Over 100 politicians from different parties pushed for clearer rules on how these tests are used. Concerns were raised about false positives, rising anxiety among parents, and the broader impact of public funding for such screenings.

Since NIPT was introduced in Germany around 2013, invasive prenatal procedures like amniocentesis have dropped sharply. Before 2013, around 100,000 invasive tests were carried out each year. By 2023, that number fell below 30,000. The shift is due to NIPT's higher accuracy, lower risk (less than 0.1% compared to 0.5–1% for invasive tests), and cost savings. Changes in medical guidelines also played a role.

Despite this trend, the Bundestag motion highlighted an unexpected rise in invasive procedures since NIPT's rollout. Lawmakers pointed to high false-positive rates, which can cause unnecessary stress for expectant parents. SPD's Dagmar Schmidt argued against routine trisomy 21 testing, calling it ethically problematic. The proposed motion includes several measures. It calls for an expert panel to assess the effects of public health insurance covering NIPT. A new monitoring system would collect better data on test outcomes. Not all lawmakers backed the motion, however. Greens' Paula Piechotta and SPD's Carmen Wegge stressed women's right to choose prenatal testing. Meanwhile, CSU's Emmi Zeulner pushed for more transparency and education around these tests.

The debate reflects growing concerns over NIPT's ethical and practical consequences. If passed, the motion would tighten regulations, improve data collection, and ensure better-informed decisions for parents. The outcome could reshape how prenatal genetic testing is managed in Germany.